Vir Biotechnology, Inc.
VIR
$10.88
-$0.30-2.68%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 238.95M | -29.00K | 60.68M | 240.00K | -312.00K |
| Total Other Revenue | -- | -- | 3.39M | -- | 1.53M |
| Total Revenue | 238.95M | -29.00K | 64.07M | 240.00K | 1.21M |
| Cost of Revenue | 135.28M | 109.81M | 88.46M | 151.45M | 97.52M |
| Gross Profit | 103.66M | -109.84M | -24.39M | -151.21M | -96.31M |
| SG&A Expenses | 30.20M | 23.34M | 23.62M | 22.23M | 22.28M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 165.48M | 133.15M | 112.07M | 173.68M | 119.80M |
| Operating Income | 73.47M | -133.18M | -48.00M | -173.44M | -118.59M |
| Income Before Tax | 80.26M | -125.53M | -43.06M | -162.97M | -110.79M |
| Income Tax Expenses | 179.00K | 170.00K | -137.00K | 168.00K | 170.00K |
| Earnings from Continuing Operations | 80.08M | -125.70M | -42.92M | -163.14M | -110.96M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 80.08M | -125.70M | -42.92M | -163.14M | -110.96M |
| EBIT | 73.47M | -133.18M | -48.00M | -173.44M | -118.59M |
| EBITDA | 76.27M | -130.37M | -45.10M | -170.45M | -115.67M |
| EPS Basic | 0.48 | -0.85 | -0.31 | -1.17 | -0.80 |
| Normalized Basic EPS | 0.31 | -0.54 | -0.18 | -0.74 | -0.49 |
| EPS Diluted | 0.47 | -0.85 | -0.31 | -1.17 | -0.80 |
| Normalized Diluted EPS | 0.30 | -0.54 | -0.18 | -0.74 | -0.49 |
| Average Basic Shares Outstanding | 167.72M | 147.36M | 139.23M | 138.93M | 138.45M |
| Average Diluted Shares Outstanding | 168.88M | 147.36M | 139.23M | 138.93M | 138.45M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |